Prevention of recurrent ischemic stroke

American Family Physician

Volumn 76, Issue 3, 2007, Pages

  Dickerson, Lori M ^a   Carek, Peter J ^a   Quattlebaum, Robert Glen ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ALCOHOL; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CLOPIDOGREL; DIPYRIDAMOLE; INDAPAMIDE; PERINDOPRIL; SIMVASTATIN; TICLOPIDINE; WARFARIN;

ALCOHOL CONSUMPTION; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DIABETES MELLITUS; DIARRHEA; DRUG COST; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MALE; OBESITY; PATIENT SAFETY; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; RASH; RECURRENT DISEASE; RISK FACTOR; SMOKING CESSATION; STENT; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; BRAIN ISCHEMIA; CAROTID ARTERY DISEASES; CEREBROVASCULAR ACCIDENT; ENDARTERECTOMY, CAROTID; HEMATOLOGIC AGENTS; HUMANS; RECURRENCE; RISK FACTORS; STENTS; THROMBOLYTIC THERAPY;

EID: 34547693327     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [Published corrections appear in Circulation 2006;113:e696 and Circulation 2006;114:e630]. Circulation 2006;113:e85-e151.
2. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, et al., for the TIA Working Group. Transient ischemic attack - proposal for a new definition. N Engl J Med 2002;347:1713-6.
3. Iwashyna TJ, Zhang JX, Christakis NA. Disease-specific patterns of hospice and related healthcare use in an incidence cohort of seriously ill elderly patients. J Palliat Med 2002;5:531-8.
4. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577-617.
5. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 suppl):483S-512S.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al., for the National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, and the National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [Published correction appears in JAMA 2003;290:197]. JAMA 2003;289:2560-72.
7. Ruland S, Richardson D, Hung E, Brorson JR, Cruz-Flores S, Felton WL 3rd, et al., for the AAASPS Investigators. Predictors of recurrent stroke in African Americans. Neurology 2006;67:567-71.
8. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004;62:569-73.
9. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003;34:2741-8.
10. Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Fulan A, Goldstein LB, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056-83.
11. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack [Published corrections appear in Lancet 2001;358:1556 and Lancet 2002;359:2120]. Lancet 2001;358:1033-41.
12. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [Published correction appears in BMJ 1999;318:29]. BMJ 1998;317:703-13.
13. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al., for the National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [Published correction appears in Circulation 2004;110:763]. Circulation 2004;110:227-39.
14. Collins R, Armitage J, Parish S, Sleight P, Peto R, for the Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004;363:757-67.
15. Amarenco P, Bogousslavsky J, Callahan A III, Goldstein LB, Hennerici M, Rudolph AE, et al., for the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-59.
16. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients [Published correction appears in BMJ 2002;324:141]. BMJ 2002;324:71-86.
17. The SALT Collaborative Group. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991;338:1345-9.
18. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Baggish JS, Bhatt DL, et al. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. Am J Cardiol 2005;95:1218-22.
19. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials [Published correction appears in JAMA 2006;295:2002]. JAMA 2006;295:306-13.
20. U.S. Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale. Accessed March 9, 2007, at: http://www.ahrq.gov/clinic/3rduspstf/aspirin/asprr.htm.
21. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
22. Plavix - clopidogrel bisulfate tablets [Prescribing information]. New York, N.Y.: Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, 2006. Accessed March 9, 2007, at: http://products.sanofi-aventis.us/plavix/plavix. html.
23. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, for the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation [Published corrections appear in N Engl J Med 2001;345:1716 and N Engl J Med 2001;345:1506]. N Engl J Med 2001;345:494-502.
24. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, et al., for the CREDO Investigators. Clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial [Published correction appears in JAMA 2003;289:987]. JAMA 2002;288:2411-20.
25. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al., for the MATCH Investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364:331-7.
26. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al., for the CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.
27. Aggrenox (aspirin/extended-release dipyridamole) [Prescribing information]. Ridgefield, Conn.: Boehringer Ingelheim Pharmaceuticals, Inc., 2006. Accessed March 9, 2007, at: http://bidocs.com/renetnt:/ Prescribing+Information/PIs/Aggrenox+Caps/Aggrenox.pdf.
28. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neuro Sci 1996;143:1-13.
29. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A, for the ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial [Published correction appears in Lancet 2007;369:274]. Lancet 2006;367:1665-73.
30. Diener HC. Prevention regimen for effectively avoiding second strokes. Accessed March 9, 2007, at: http://www.strokecenter.org/trials/Trial-Detail. aspx?tid=495.
31. Diener HC, Darius H, Bertrand-Hardy JM, Humphreys M. Cardiac safety in the European Stroke Prevention Study 2 (ESPS2). Int J Clin Pract 2001;55:162-3.
32. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, et al., for the Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444-51.
33. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al., for the Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-16.
34. Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, et al. Carotid endarterectomy - an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005;65:794-801.
35. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, et al., for the EVA-3S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355:1660-71.